326 related articles for article (PubMed ID: 8797601)
1. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines.
Tallett A; Chilvers ER; MacKinnon AC; Haslett C; Sethi T
Peptides; 1996; 17(4):665-73. PubMed ID: 8804078
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M
Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins.
Krystal GW; Carlson P; Litz J
Cancer Res; 1997 Jun; 57(11):2203-8. PubMed ID: 9187122
[TBL] [Abstract][Full Text] [Related]
5. Effect of tyrphostin combined with a substance P related antagonist on small cell lung cancer cell growth in vitro.
Seckl MJ; Rozengurt E
Eur J Cancer; 1996 Feb; 32A(2):342-5. PubMed ID: 8664052
[TBL] [Abstract][Full Text] [Related]
6. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation.
Chess PR; Ryan RM; Finkelstein JN
Pediatr Res; 1994 Oct; 36(4):481-6. PubMed ID: 7529394
[TBL] [Abstract][Full Text] [Related]
9. Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells.
Roelle S; Grosse R; Buech T; Chubanov V; Gudermann T
Oncogene; 2008 Mar; 27(12):1737-48. PubMed ID: 17906699
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
[TBL] [Abstract][Full Text] [Related]
12. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
Tsuda T; Kusui T; Jensen RT
Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells.
Matsumoto Y; Kawatani M; Simizu S; Tanaka T; Takada M; Imoto M
Anticancer Res; 2000; 20(5A):3123-9. PubMed ID: 11062732
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
15. Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes.
Rozengurt E
Cancer Surv; 1995; 24():81-96. PubMed ID: 7553664
[TBL] [Abstract][Full Text] [Related]
16. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
Peterson G; Barnes S
Cell Growth Differ; 1996 Oct; 7(10):1345-51. PubMed ID: 8891338
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
18. Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo.
Sethi T; Langdon S; Smyth J; Rozengurt E
Cancer Res; 1992 May; 52(9 Suppl):2737s-2742s. PubMed ID: 1314136
[TBL] [Abstract][Full Text] [Related]
19. EGF-dependent and independent programmed cell death pathways in NCI-H596 nonsmall cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Biochem Biophys Res Commun; 1998 Apr; 245(3):939-45. PubMed ID: 9588219
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
Martinson EA; Scheible S; Presek P
Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
